STL Volume 13 Number 2

3 POSTS 0 COMMENTS
Purchase PDF for $2.79Update on Drugs and Drug News – March 2008
Update on Anti-psoriatic Agent Adalimumab (Humira®), Antihistamine (Claritin®), HIV drug Etravirine (Intelence™) and news about new antioxidant, coffeeberry (REVALÉSKIN™, Stiefel Laboratories)
Drug Treatments for Skin Disease Introduced in 2007
Treatments introduced in 2007 including Adapalene Gel 0.3% Differin®, Drospirenone/ Ethinyl Estradiol Yaz®, Tretinoin 0.05% Gel Anthralin®, Daptomycin for Injection CUBICIN®, Retapamulin Ointment 1% Altabax®, Tinidazole Tablets Tindamax® and other treatments.
An Update on New and Emerging Options for the Treatment of Vitiligo
Vitiligo is an acquired leukoderma that results from the loss of epidermal melanocytes, and is characterized by macules and patches of depigmented skin. With a relatively high rate of prevalence, vitiligo occurs in localized, generalized, or segmental patterns; it can run a rapidly progressive course or remain stationary.